XML 22 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets, as of December 31 - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
ASSETS    
Cash and cash equivalents $ 3,619 $ 1,291
Trade receivables (net of allowances of $42 at December 31, 2020 and $35 at December 31, 2019) 2,297 2,212
Other receivables (net of allowances of $42 at December 31, 2020 and $44 at December 31, 2019) 657 715
Inventories, net 2,647 2,546
Other current assets 759 866
Total current assets 9,979 7,630
Property, plant and equipment, net 9,026 8,733
Operating lease right of use assets 638 568
Goodwill 21,895 20,848
Intangible assets, net 18,482 17,957
Prepaid pension assets 672 516
Deferred income taxes 790 726
Equity method investments [1] 6,036 7,178
Other assets 292 359
TOTAL ASSETS 67,810 64,515
LIABILITIES    
Short-term borrowings 29 2,638
Current portion of long-term debt 2,741 1,581
Accounts payable 6,209 5,853
Accrued marketing 2,130 1,836
Accrued employment costs 834 769
Other current liabilities 3,216 2,645
Total current liabilities 15,159 15,322
Long-term debt 17,276 14,207
Long-term operating lease liabilities 470 403
Deferred income taxes 3,346 3,338
Accrued pension costs 1,257 1,190
Accrued postretirement health care costs 346 387
Other liabilities 2,302 2,351
TOTAL LIABILITIES 40,156 37,198
Commitments and Contingencies
EQUITY    
Common Stock, no par value (5,000,000,000 shares authorized and 1,996,537,778 shares issued at December 31, 2020 and December 31, 2019) 0 0
Additional paid-in capital 32,070 32,019
Retained earnings 28,402 26,615
Accumulated other comprehensive losses (10,690) (10,254)
Treasury stock, at cost (577,363,557 shares at December 31, 2020 and 561,531,524 shares at December 31, 2019) (22,204) (21,139)
Total Mondelēz International Shareholders’ Equity 27,578 27,241
Noncontrolling interest 76 76
TOTAL EQUITY 27,654 27,317
TOTAL LIABILITIES AND EQUITY $ 67,810 $ 64,515
[1] Includes a basis difference of approximately $519 million as of December 31, 2020 and $333 million as of December 31, 2019 between the U.S. GAAP accounting basis for our equity method investments and the U.S. GAAP accounting basis of our investees’ equity.